A stem cell line regulating porcine OCT4 gene expression and its construction method
By constructing lentiviral vectors for overexpression and knockdown of porcine OCT4, and preparing OCT4 overexpression and knockdown stem cell lines, the problem of regulating porcine OCT4 gene expression was solved, enabling research on gene regulation during the embryonic development of small-eared pigs, which has important genetic breeding value.
Patent Information
- Application Number
- CN202510633432.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-05-16
- Publication Date
- 2026-11-17
AI Technical Summary
Existing technologies are insufficient to effectively regulate the expression of the porcine OCT4 gene, thus hindering research into the regulatory mechanisms of somitogenesis and vertebral number variation during small-eared pig embryonic development.
By constructing lentiviral vectors for overexpressing and knocking down porcine OCT4, and using 293T cells to prepare overexpressing and knocking down lentiviruses, OCT4 overexpressing and knocking down stem cell lines were obtained by infecting stem cells, which were then used to regulate the expression of porcine OCT4.
We successfully constructed OCT4 overexpression and knockdown stem cell lines to study gene expression regulation mechanisms in the early embryonic development stage of small-eared pigs, which has important genetic breeding significance.
Smart Images

Figure CN123108154A_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of genetic engineering technology, specifically relating to a stem cell line that regulates the expression of the porcine OCT4 gene and its construction method. Background Technology
[0002] Gene overexpression involves using biological, chemical, and physical methods to maintain a stable high expression level of a specific gene in cells or organisms, thereby enhancing the function of that gene. This is used in gene function research, disease mechanism research, and drug screening and development. Gene knockdown refers to using RNA interference to target the RNA of a target gene in cells or organisms, causing its degradation and reducing its expression level. Gene knockdown is achieved by synthesizing small interfering RNA (siRNA), stable antisense RNA (shRNA), and CRISPRi, and is an important tool for studying gene function. shRNA interfering RNA sequences are relatively long and can form stable hairpin structures, resulting in higher effectiveness.
[0003] The OCT4 gene is a key transcription factor primarily involved in embryonic development, stem cell self-renewal, and pluripotency maintenance. It may also influence different stages of embryonic development, including key processes such as body axis formation and organ development. Vertebral number and development are regulated by numerous genes, especially in the early stages of embryonic development, involving complex gene networks, including the Hox gene group (closely related to body axis patterns and vertebral segment development). OCT4 may regulate vertebral development and differentiation through interactions with these genes, thereby affecting vertebral number variation. To further investigate the regulatory mechanisms of OCT4 and vertebral number variation in domestic pigs, targeted knockout or overexpression of OCT4 can be used to observe its effects on vertebral development in pig embryos and explore its role in vertebral number variation. Summary of the Invention
[0004] This invention provides a stem cell line for regulating the expression of the porcine OCT4 gene and a method for constructing it. The constructed OCT4 overexpression and knockdown stem cell lines can be used to study the regulatory mechanisms in the early embryonic development stage of small-eared pigs, which is of great significance for the genetic breeding of small-eared pigs.
[0005] This invention provides the application of a reagent for regulating the expression of porcine OCT4 in the preparation of a detection kit for somitogenesis during the embryonic development of small-eared pigs.
[0006] In a preferred embodiment of the present invention, the reagent for regulating the expression of porcine OCT4 includes a reagent for overexpressing porcine OCT4 or a reagent for inhibiting the expression of porcine OCT4.
[0007] The present invention also provides a biological material for regulating the expression of porcine OCT4, comprising any one of the following: an overexpression vector, siRNA, shRNA, and CRISPRi.
[0008] The present invention also provides a lentiviral vector for overexpressing porcine OCT4, comprising a lentiviral backbone vector using pLVX-AcGFP-N1.
[0009] In a preferred embodiment of the present invention, the CDS sequence of the porcine OCT4 is inserted between XhoI and EcoRI of the pLVX-AcGFP-N1.
[0010] The present invention also provides a lentiviral vector for knocking down porcine OCT4, comprising a lentiviral backbone vector with pPLK-GFP-puro as the lentiviral backbone vector, and the target sequence comprising any one of the following: the target sequence shRNA1 shown in SEQ ID No. 1, the target sequence shRNA2 shown in SEQ ID No. 2, and the target sequence shRNA3 shown in SEQ ID No. 3.
[0011] In a preferred embodiment of the present invention, the nucleotide sequences of the primer pairs designed for the target sequence shRNA1 are shown in SEQ ID No. 4 to SEQ ID No. 5; the nucleotide sequences of the primer pairs designed for the target sequence shRNA2 are shown in SEQ ID No. 6 to SEQ ID No. 7; and the nucleotide sequences of the primer pairs designed for the target sequence shRNA3 are shown in SEQ ID No. 8 to SEQ ID No. 9.
[0012] The present invention also provides a porcine OCT4 overexpressing lentivirus prepared using the above-mentioned overexpressing lentiviral vector.
[0013] The present invention also provides a swine OCT4 knockdown lentivirus prepared using the above-described knockdown lentiviral vector.
[0014] The present invention also provides a stem cell line that regulates the expression of porcine OCT4 obtained after being infected by the above-mentioned overexpressing lentivirus or the above-mentioned knockdown lentivirus.
[0015] Beneficial Effects: This invention provides a stem cell line regulating porcine OCT4 expression and its application in elucidating the regulatory mechanism of vertebral number variation in domestic pigs. Using 293T cells as the production host, overexpressing and knocking down lentiviral vectors were prepared. These vectors were then used to infect porcine OCT4-overexpressing and knockdown-expressing stem cell lines. The OCT4-overexpressing and knockdown-expressing stem cell lines obtained by this invention can be used to study the gene expression regulatory mechanism during somitogenesis in small-eared pig embryos. Attached Figure Description
[0016] Figure 1 This is a spectrum of the porcine-derived OCT4 vector of the present invention;
[0017] Figure 2 This is an electrophoresis image of the porcine OCT4 plasmid from this invention;
[0018] Figure 3 This is a fluorescence image of viral infection in mesenchymal stem cells from small-eared pigs in Yunnan Province, as presented in this invention.
[0019] Figure 4 This is a diagram showing the OCT4 gene expression results in the overexpression cell line of this invention, where A represents the OCT4 mRNA expression level and B represents the nucleic acid detection results.
[0020] Figure 5 This is a diagram showing the expression results of OCT4 protein in the overexpression cell line of this invention;
[0021] Figure 6 The diagram shows the results of OCT4 gene expression knockdown in the cell line of this invention. Figure A shows the comparison of OCT4 mRNA expression after infection with three shRNAs, Figure B shows the OCT4 mRNA expression level after shRNA3 infection, and Figure C shows the nucleic acid detection results after shRNA3 infection.
[0022] Figure 7 This is a diagram showing the results of knocking down OCT4 protein expression in the cell line of this invention;
[0023] Figure 8 The images show the OCT4 affinity detection results of bone marrow mesenchymal stem cells from Yunnan small-eared pigs before and after OCT4-Motif mutation, where A is the DNAPull-down result image and B is the protein detection result after DNAPull-down.
[0024] Figure 9The images show the activity detection results of OCT4-Motif mutation sites in bone marrow mesenchymal stem cells and overexpressing cell lines of Yunnan small-eared pigs, as presented in this invention. A is a schematic diagram of the fluorescent dual reporter vector design, B is the activity detection result of OCT4-Motif mutation sites in bone marrow mesenchymal stem cells of Yunnan small-eared pigs, and C is the activity detection result of OCT4-Motif mutation sites in overexpressing cell lines. Detailed Implementation
[0025] This invention provides the application of a reagent for regulating the expression of porcine OCT4 in the preparation of a detection kit for somitogenesis during the embryonic development of small-eared pigs.
[0026] The OCT4 gene described in this invention is highly expressed in embryonic stem cells, embryonic germ cells, and various adult stem cells, and plays an important role in maintaining the pluripotency and self-renewal of stem cells. In one embodiment, the porcine OCT4 gene described in this invention is derived from the Yunnan Small-eared Pig, with a GeneID of NM001113060.1.
[0027] The reagents for regulating the expression of porcine OCT4 described in this invention include reagents that overexpress porcine OCT4 or reagents that inhibit the expression of porcine OCT4. In one embodiment of this invention, a lentivirus is constructed using a lentiviral expression vector, and then the corresponding stem cell line is obtained by infecting stem cells with the lentivirus.
[0028] The present invention also provides a biological material for regulating the expression of porcine OCT4, comprising any one of the following: an overexpression vector, siRNA, shRNA, and CRISPRi.
[0029] The present invention also provides a lentiviral vector for overexpressing porcine OCT4, comprising a lentiviral backbone vector using pLVX-AcGFP-N1.
[0030] In a preferred embodiment of the present invention, the CDS sequence of the porcine OCT4 is inserted between XhoI and EcoRI of the pLVX-AcGFP-N1 sequence, wherein the CDS sequence of the porcine OCT4 is shown in SEQ ID No. 10. In another embodiment, the CDS sequence of the porcine OCT4 is modified by adding the restriction enzyme CTCGAG to the 5' end and the restriction enzyme GAATTC to the 3' end before insertion between XhoI and EcoRI of the pLVX-AcGFP-N1 sequence, thereby obtaining the desired result. Figure 1 The overexpressed lentiviral vector is shown.
[0031] The present invention also provides a lentiviral vector for knocking down porcine OCT4, comprising a lentiviral backbone vector with pPLK-GFP-puro as the lentiviral backbone vector, and the target sequence comprising any one of the following: the target sequence shRNA1 shown in SEQ ID No. 1, the target sequence shRNA2 shown in SEQ ID No. 2, and the target sequence shRNA3 shown in SEQ ID No. 3.
[0032] This invention designs interfering plasmid primers based on the target site of the vector pPLK-GFP-puro, wherein the target site sequence can be any one of SEQ ID No. 1 to SEQ ID No. 3:
[0033] shRNA1 (SEQ ID No. 1): AGGATGTGGTCCGCGTGTGGT;
[0034] shRNA2 (SEQ ID No. 2): AGCAGCTCGGGCTAGAGAA;
[0035] shRNA3 (SEQ ID No. 3): CCCATGCCTTACGACTTACAA.
[0036] In a preferred embodiment of the present invention, the nucleotide sequences of the primer pairs designed for the target sequence shRNA1 are shown in SEQ ID No. 4 to SEQ ID No. 5; the nucleotide sequences of the primer pairs designed for the target sequence shRNA2 are shown in SEQ ID No. 6 to SEQ ID No. 7; and the nucleotide sequences of the primer pairs designed for the target sequence shRNA3 are shown in SEQ ID No. 8 to SEQ ID No. 9.
[0037] shRNA1-F (SEQ ID No. 4):GATCCGAGGATGTGGTCCGCGTGTGGTTTC AAGAGAACCACACGCGGACCACATCCTCTTTTTTG;
[0038] shRNA1-R (SEQ ID No. 5):AATTCAAAAAAGAGGATGTGGTCCGCGTG TGGTTCTCTTGAAACCACACGCGGACCACATCCTCG;
[0039] shRNA2-F (SEQ ID No. 6):GATCCGAGCAGCTCGGGCTAGAGAATTTC AAGAGAATTCTCTAGCCCGAGCTGCTCTTTTTTG;
[0040] shRNA2-R (SEQ ID No. 7):AATTCAAAAAAGAGCAGCTCGGGCTAGAG AATTCTCTTGAAATTCTCTAGCCCGAGCTGCTCG;
[0041] shRNA3-F (SEQ ID No. 8):GATCCGCCCATGCCTTACGACTTACAATTT CAAGAGAATTGTAAGTCGTAAGGCATGGGCTTTTTTG;
[0042] shRNA3-R (SEQ ID No. 9): AATTCAAAAAAGCCCATGCCTTACGACTTACAAATTCTCTTGAAATTGTAAGTCGTAAGGCATGGGCG.
[0043] The primer annealing system of the present invention, in 50 μl units, includes: 5 μl of upstream primer, 5 μl of downstream primer, 25 μl of 10×NEBBuffer, and 35 μl of ddH2O.
[0044] Reaction procedure: 95℃ for 4 min, 70℃ for 10 min, then naturally cooled to room temperature in a 70℃ water bath.
[0045] Annealed primers were ligated into the T vector. The pPLK-GFP-puro vector was double-digested with BamHI and EcoRI. The T vector containing the target sequence was then ligated into the pPLK-GFP-puro vector. After competent transformation, single clones were selected and sequenced for verification to obtain the knockdown lentiviral vector.
[0046] The present invention also provides a porcine OCT4 overexpressing lentivirus prepared using the above-mentioned overexpressing lentiviral vector.
[0047] In one embodiment of the present invention, 293T cells are used as the production host for the overexpressing lentivirus. After resuscitation, the 293T cells are spread in a gelatin-coated culture dish, such as a 100mm culture dish coated with gelatin, where the gelatin concentration is 0.2% (m / v). Transfection is performed when the 293T cell density reaches 50-60%. During transfection, in addition to the overexpressing lentivirus vector, plasmids pMD2.G and psPAX2 are packaged, and the mass ratio of the overexpressing lentivirus vector, pMD2.G, and psPAX2 is 2:1:2.
[0048] The present invention involves culturing the cells after transfection, which includes replacing the culture medium with fresh medium 6 hours after transfection and culturing for another 48 hours. The cultured cells are then centrifuged, and the supernatant is collected. In one embodiment, the centrifugation is performed at 500g for 5 minutes.
[0049] The present invention also provides a swine OCT4 knockdown lentivirus prepared using the above-described knockdown lentiviral vector.
[0050] The method for constructing the knockdown lentivirus described in this invention is the same as the method for constructing the overexpression lentiviral vector described above, and will not be repeated here.
[0051] The present invention also provides a stem cell line that regulates the expression of porcine OCT4 obtained after being infected by the above-mentioned overexpressing lentivirus or the above-mentioned knockdown lentivirus.
[0052] In one embodiment of this invention, target stem cells are plated in 6-well plates, infected with lentiviral solution, and screened with puromycin to obtain OCT4 overexpressing stem cell lines and knockdown stem cell lines. Before infection with the lentivirus, this invention requires a stem cell density of 60-70%. During infection, an equal volume of the lentiviral solution and stem cell culture medium is mixed, polybrene is added, and after lentiviral infection, screening is performed using puromycin at a concentration of 1 μg / ml in one embodiment.
[0053] To further illustrate the present invention, the following detailed description, in conjunction with embodiments, of a stem cell line for regulating the expression of the porcine OCT4 gene and its construction method provided by the present invention, should not be construed as limiting the scope of protection of the present invention.
[0054] Unless otherwise specified, the reagents and stem cells used in the embodiments of this invention are all from conventional sources in the art.
[0055] α-MEM complete culture medium: 43ml α-MEM basal medium, 5ml FBS, 0.5ml 100mM Sodium Pyruvate Solution, 0.5ml 100×MEM Non-Essential Amino Acids Solution, 0.5ml GlutaMAX TM Supplement, 10 ng / ml FGF and 0.5 ml penicillin antibody, including α-MEM medium, FBS, 100 mM Sodium Pyruvate Solution, 100×MEM Non-Essential Amino Acids Solution, and GlutaMAX. TMSupplement was acquired by Gibco; FGF was acquired by Peprotech.
[0056] In this case, the bone marrow mesenchymal stem cells of Yunnan small-eared pigs were obtained from the Kunming Cell Bank of the Chinese Academy of Sciences.
[0057] In this embodiment, the RNA extraction kit was purchased from TransGen Biotech; the reverse transcription kit, ... qPCR Green MasterMix was purchased from Novizan; RAPI protein lysis buffer and BCA protein concentration assay kit were purchased from Thermo Fisher; One-Step PAGE Gel Fast Preparation Kit (10%) was purchased from Novizan; OCT4 antibody was purchased from ABcam; GAPDH antibody was purchased from ABclonal; Anti-rabbit IgG and HRP-linked Antibody were purchased from CST; and chemiluminescence reagents were purchased from Beyotime.
[0058] Example 1: Culture of bone marrow mesenchymal stem cells from Yunnan small-eared pigs
[0059] (1) Resuscitation of bone marrow mesenchymal stem cells from Yunnan small-eared pigs:
[0060] The frozen cells were removed from liquid nitrogen, thawed rapidly in a 37°C water bath, centrifuged at 1000 rpm for 3 min, the cryoprotectant was removed, and the cells were resuspended in α-MEM complete culture medium for culture.
[0061] (2) Passaging of bone marrow mesenchymal stem cells from Yunnan small-eared pigs:
[0062] After the revived stem cells have reached full maturity, they are passaged at a ratio of 1:2 to 1:3 for subsequent infection and other experiments.
[0063] Example 2: Synthesis and Design of Porcine OCT4 Overexpression Vector
[0064] The CDS sequence of the porcine OCT4 gene was confirmed on NCBI. The 5' end was augmented with the restriction enzyme sequence CTCGAG, and the 3' end with the restriction enzyme sequence GAATTC. The designed sequence was sent to PPL for the synthesis of the overexpression lentiviral vector. The porcine OCT4 vector map is shown below. Figure 1 As shown, the electrophoresis results of the synthesized plasmid are as follows: Figure 2 As shown.
[0065] Example 3: Design and synthesis of porcine OCT4 knockdown plasmid
[0066] Interference plasmid primers were designed based on the target sites of the vector pPLK-GFP-puro, with target sequences shown in SEQ ID No. 1 to SEQ ID No. 3. Primer pairs SEQ ID No. 4 and SEQ ID No. 5, SEQ ID No. 6 and SEQ ID No. 7, and SEQ ID No. 8 and SEQ ID No. 9 were designed and sent to the company to synthesize the knockdown lentiviral vector.
[0067] Example 4: Preparation of lentivirus by OCT4 overexpression and knockdown
[0068] Resuscitate 293T cells, passage them twice, and then plate them in 100mm culture dishes coated with 0.2% gelatin. When the cell density reaches 50-60%, perform transfection. The transfection system is shown in Table 1.
[0069] Table 1 Transfection System
[0070]
[0071] Replace with fresh culture medium 6 hours after transfection. Collect the viral supernatant 48 hours after medium replacement, centrifuge at 500g for 5 min, filter through a 0.45μM filter to obtain slow virus, and store temporarily at 4℃.
[0072] In this embodiment, Lipofectmin2000 and Opti-MEM were purchased from Gibco, the target plasmid was synthesized from PPL, and the packaging plasmid was derived from Zhang Yaping's group at the Kunming Institute of Zoology.
[0073] 293T cells were plated in 6-well plates, 2×10⁻⁶. 5 The number of cells / well, after 5 days of growth, is approximately 39 × 10⁻⁶. 5 One hole / hole.
[0074] The calculation results are as follows:
[0075] Table 2. Viral titers corresponding to overexpression of empty vectors
[0076] pLVX-AcGFP-N1 Well / cell count (100,000) Virus titer Dilute 1000 times 24.9 <![CDATA[1.27×10 8 ]]> Dilute 10,000 times 4.2 <![CDATA[2.2×10 8 ]]>
[0077] Diluted 1000 times: (24.9 / 39) × 2 × 10 5 / 1×10 3 =1.27×10 8 PFU / ml.
[0078] Diluted 10000 times: (4.2 / 39) × 2 × 10 5 / 1×10 4 =2.2×10 8 PFU / ml.
[0079] Table 3. Overexpression Virus Titer
[0080] pLVX-OCT4-AcGFP-N1 Well / cell count (100,000) Virus titer Dilute 1000 times 27.69 <![CDATA[1.42×10 8 ]]> Dilute 10,000 times 4.485 <![CDATA[2.3×10 8 ]]>
[0081] Diluted 1000 times: (27.69 / 39) × 2 × 10 5 / 1×10 3 =1.42×10 8 PFU / ml.
[0082] Diluted 10000 times: (4.485 / 39) × 2 × 10 5 / 1×10 4 =2.3×10 8 PFU / ml.
[0083] The average titer from 1000-fold and 10000-fold dilutions is the final viral titer in PFU.
[0084] pLVX-AcGFP-N1: 1.735 × 10 8 PFU / ml;
[0085] pLVX-OCT4-AcGFP-N1: 1.86 × 10 8 PFU / ml
[0086] Example 5: OCT4 overexpression and shRNA knockdown lentivirus infection of Yunnan small-eared pig bone marrow mesenchymal stem cells
[0087] (1) Take 5 × 10⁵ stem cells from the second passaged stem cells after resuscitation in Example 1. 4 / ml of the plate is placed in a 6-well plate.
[0088] (2) When the cell density reaches about 60-70%, infect the cells by mixing the virus solution with the cell culture medium at a ratio of 1:1 (2 ml in total), and then add 2 μL of polybrena.
[0089] (3) Re-infection occurred 24 hours later.
[0090] (4) After infection, observe the green fluorescence, bright field, and fluorescent cells using an inverted fluorescence microscope. Figure 3 As shown.
[0091] (5) Infected cells were screened with 1 μg / ml puromycin and overexpressed and knocked-down cell lines were obtained after 7 days of continuous screening.
[0092] Example 6: Detection of OCT4 expression level in bone marrow mesenchymal stem cells of Yunnan small-eared pigs
[0093] In Example 5, cells infected with an empty vector were used as the control group, cells infected with OCT4 overexpressing lentivirus were used as the overexpression group, and cells infected with shRNA knockdown lentivirus were used as the knockdown group.
[0094] Total RNA was extracted using a full-length gold RNA extraction kit, and the expression of OCT4 mRNA was detected by quantitative real-time PCR after reverse transcription. Overexpression results are shown below. Figure 4 As shown in A, Figure 4 Image B shows the results of nucleic acid electrophoresis validation of the overexpression qRT-PCR products, with 4 replicate wells per group. Knockdown results are shown below. Figure 6 As shown in Figure A, this compares the knockdown effects of three designed target points, with target number 3 showing the most significant knockdown effect. Figure 6 Figure B shows the repeat results of interfering RNA 3. Figure 6 The middle C is the result of nucleic acid electrophoresis to verify the product of knockdown qRT-PCR, with 4 replicate wells in each group.
[0095] Total protein was obtained from RAPI protein lysis buffer, and Western blotting was performed at a protein loading rate of 30 μg. The results were as follows: Figure 5 The overexpression group showed OCT4 protein expression and Figure 7 The OCT4 protein expression in the knockdown group is shown.
[0096] Table 4 Primer Sequence Information for Quantitative Real-Time PCR
[0097]
[0098] Table 5 Antibody information for Western Blot experiments
[0099] Antibody Dilution ratio OCT4 1:1500 GAPDH 1:2000 Anti-RabbitIgG,HRP-linkedAntibody 1:2000
[0100] The results showed that, compared with the control group, the expression levels of OCT4 mRNA and protein were significantly upregulated in the overexpression group and significantly downregulated in the shRNA3 knockdown group, indicating that the bone marrow mesenchymal stem cell line of Yunnan small-eared pigs with OCT4 overexpression and knockdown was successfully constructed.
[0101] Example 7: OCT4 Affinity Detection of Bone Marrow Mesenchymal Stem Cells from Yunnan Small-eared Pigs
[0102] Bone marrow mesenchymal stem cells from Yunnan small-eared pigs in Example 1 were used to extract nucleoproteins for OCT4 affinity detection in small-eared pigs. The Yunnan small-eared pigs had a homozygous wild-type OCT4-Motif genotype. DNA probes were designed targeting OCT4-Motif as shown in Table 6, including biotin-labeled probe primers for the porcine OCT4-Motif mutation site, a porcine OCT4-Motif 8bp mutation probe primer, and a porcine OCT4-Motif mutation site probe primer. The synthesized probe primers were annealed to form double strands. 1 μg of DNA probe was mixed with 100 μg of nucleoprotein and added to Streptavidin-agarose G magnetic beads. The beads were resuspended and incubated at 4°C for 1 hour. The beads were washed three times with ice-cold PBS, the supernatant was removed, and the precipitate was collected for SDS-PAGE analysis. The results were as follows: Figure 8 As shown in Figure A, the biotin-labeled OCT4-Motif mutant probe exhibits high band intensity with the nucleoprotein, indicating a stronger affinity for OCT4 compared to the wild type. Western blot analysis of the collected precipitate yielded the following results: Figure 8 As shown in Figure B, the expression level of OCT4 is higher after the OCT4-Motif mutation compared to the wild type.
[0103] Table 6. Information on OCT4-Motif probes from Yunnan small-eared pigs.
[0104]
[0105] Example 8: Detection of OCT4-Motif Mutation Site Activity in Bone Marrow Mesenchymal Stem Cells from Yunnan Small-eared Pigs
[0106] Previous studies have found that in small-eared pigs, the number of thoracic and lumbar vertebrae or ribs increases in some individuals after OCT4-Motif mutation. The FOS gene is a major candidate gene affecting the variation in the number of thoracic vertebrae in domestic pigs, and mutations in the FOS gene may lead to abnormal vertebral development, thus affecting the normal formation of vertebrae. In this embodiment, an FOS promoter was inserted into the PGL3-basic vector backbone as a reference, and then the OCT4-Motif mutation site sequence was inserted. Cells infected with the empty vector from Example 5 were used, and the overexpressing cells selected after OCT4 overexpression lentivirus infection were subjected to fluorescence reporter assays to verify changes in the activity of the mutation site, obtaining the following results: Figure 9 The results are shown in the figure.
[0107] The results showed that OCT4-Motif activity was enhanced in empty vector cells, but weakened in OCT4-overexpressing cells, indicating that OCT4-Motif may be one of the causal mutations affecting the number of vertebrae and ribs in domestic pigs.
[0108] Although the above embodiments have provided a detailed description of the present invention, they are only some embodiments of the present invention, and not all embodiments. People can obtain other embodiments based on these embodiments without creative effort, and these embodiments all fall within the protection scope of the present invention.
Claims
1. The application of a reagent that regulates the expression of porcine OCT4 in the preparation of a detection kit for somitogenesis during the embryonic development of small-eared pigs.
2. The application according to claim 1, characterized in that, The reagents used to regulate the expression of porcine OCT4 include reagents that overexpress porcine OCT4 or reagents that inhibit the expression of porcine OCT4.
3. A biomaterial for regulating the expression of porcine OCT4, characterized in that, Including any of the following: overexpression vectors, siRNA, shRNA, and CRISPRi.
4. A lentiviral vector overexpressing porcine OCT4, characterized in that, This includes using pLVX-AcGFP-N1 as a lentiviral backbone vector.
5. The overexpression lentiviral vector according to claim 4, characterized in that, This includes inserting the CDS sequence of the porcine OCT4 between the XhoI and EcoRI of the pLVX-AcGFP-N1.
6. A lentiviral vector for knocking down porcine OCT4, characterized in that, This includes lentiviral vectors with pPLK-GFP-puro as the backbone, and target sequences including any one of the following: target sequence shRNA1 shown in SEQ ID No. 1, target sequence shRNA2 shown in SEQ ID No. 2, and target sequence shRNA3 shown in SEQ ID No.
3.
7. The knockdown lentiviral vector according to claim 6, characterized in that, The nucleotide sequences of primer pairs designed for the target sequence shRNA1 are shown in SEQ ID No. 4 to SEQ ID No. 5; the nucleotide sequences of primer pairs designed for the target sequence shRNA2 are shown in SEQ ID No. 6 to SEQ ID No. 7; and the nucleotide sequences of primer pairs designed for the target sequence shRNA3 are shown in SEQ ID No. 8 to SEQ ID No.
9.
8. A porcine OCT4 overexpressing lentivirus prepared using the overexpressing lentiviral vector of claim 5.
9. A ligand of porcine OCT4 prepared using the knockdown lentiviral vector of claim 6 or 7.
10. A stem cell line that regulates porcine OCT4 expression obtained by infection with the overexpressing lentivirus of claim 8 or the knockdown lentivirus of claim 9.
